doi: 10.3980/j.issn.2222-3959.2012.05.13.
Epub 2012 Oct 18.
Tissue factor with age-related macular degeneration
Affiliations
- PMID: 23166874
- PMCID: PMC3484712
- DOI: 10.3980/j.issn.2222-3959.2012.05.13
Item in Clipboard
Tissue factor with age-related macular degeneration
Int J Ophthalmol.
2012.
Abstract
Wet age-related macular degeneration which incidence increases year by year is a blinding eye disease, but current clinical methods of treatment on this disease are limited and the outcome is not ideal. Recent studies have found abnormally high expression of tissue factors which are targets for the treatment of wet age-related macular degeneration to achieve a certain effect in the choroidal neovascularization. Related literatures are reviewed as following.
Keywords: choroidal neovascularzation; immunotherapy; photodynamic therapy; tissue factor; wet age-related macular degeneration.
Similar articles
-
Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration.Clin Ophthalmol. 2011;5:167-70. doi: 10.2147/OPTH.S16947. Epub 2011 Feb 11. Clin Ophthalmol. 2011. PMID: 21383944 Free PMC article.
-
[Vitreomacular adhesion in HD-OCT images in the age-related macular degeneration].Klin Oczna. 2013;115(1):25-8. Klin Oczna. 2013. PMID: 23882735 Polish.
-
Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration.Expert Opin Biol Ther. 2015;15(9):1349-58. doi: 10.1517/14712598.2015.1057565. Epub 2015 Jun 16. Expert Opin Biol Ther. 2015. PMID: 26076760 Review.
-
Progression of lesion size in untreated eyes with exudative age-related macular degeneration: a meta-analysis using Lineweaver-Burk plots.JAMA Ophthalmol. 2013 Mar;131(3):335-40. doi: 10.1001/jamaophthalmol.2013.818. JAMA Ophthalmol. 2013. PMID: 23494038
-
Photodynamic therapy for polypoidal choroidal vasculopathy.Prog Retin Eye Res. 2013 Nov;37:182-99. doi: 10.1016/j.preteyeres.2013.09.003. Epub 2013 Oct 15. Prog Retin Eye Res. 2013. PMID: 24140257 Review.
Cited by
-
New Therapies of Neovascular AMD-Beyond Anti-VEGFs.Vision (Basel). 2018 Jul 30;2(3):31. doi: 10.3390/vision2030031. Vision (Basel). 2018. PMID: 31735894 Free PMC article. Review.
-
RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells.J Transl Med. 2018 Mar 13;16(1):63. doi: 10.1186/s12967-018-1434-6. J Transl Med. 2018. PMID: 29534722 Free PMC article.
-
Protection of tight junction between RPE cells with tissue factor targeting peptide.Int J Ophthalmol. 2018 Oct 18;11(10):1594-1599. doi: 10.18240/ijo.2018.10.04. eCollection 2018. Int J Ophthalmol. 2018. PMID: 30364251 Free PMC article.
-
The Contribution of Fluoride to the Pathogenesis of Eye Diseases: Molecular Mechanisms and Implications for Public Health.Int J Environ Res Public Health. 2019 Mar 8;16(5):856. doi: 10.3390/ijerph16050856. Int J Environ Res Public Health. 2019. PMID: 30857240 Free PMC article. Review.
References
-
- Li D, Li QC, Sun M. Recent advances on treatment for neovascular age-related macular degeneration. Yanke Xinjinzhan. 2010;30(8):797–800.
-
- Croce K, Libby P. Intertwining of thromhosis and inflammation in atherosclerosis. Curr Opin Hematol. 2007;14(1):55–61. - PubMed
-
- Versteeg HH, Peppelenbosch MP, Spek CA. The pleiotropic effects of tissue factor: a possible role for factor VII a -induced intracellular signalling? Thromb Haemost. 2001;86:1353–1359. - PubMed
-
- Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257–293. - PubMed
LinkOut - more resources
Full Text Sources